Bouman Clinic
Rotterdam, South Holland, 3084 LD, Netherlands
NCT Number: NCT02119949
Background: Substance abusers show impaired working memory (WM) functioning. Promising findings show training WM results in an improved working memory capacity (WMC) and a decrease of clinical symptoms in a range of disorders, including alcohol addiction.
Aim: To test the effect of a WM training in addition to treatment as usual (TAU) on substance use, craving, WMC, impulsivity, attention bias and psychopathology.
Design: A randomized double-blind placebo-controlled trial with a parallel group design. The WM training adapted to participants' WMC whereas the placebo training consisted of non-adaptive easy versions of these tasks.
Setting: Two departments of an addiction treatment clinic in Rotterdam, the Netherlands.
Participants: 120 inpatients diagnosed with an alcohol, cannabis or cocaine dependency who were in treatment as usual .
Measurements: Primary outcome measures: Substance use and craving. Secondary outcome measures: WMC, impulsivity, attention bias and psychopathology. Participants were assessed before and after 24 sessions of WM training as well as two months after the training.
Looking for future studies?
Notify Me16 year–67 year
All sexes
Interventional
Not applicable
Rotterdam, South Holland, 3084 LD, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The working memory training started the day after the pre-test and included 24 sessions of 25 minutes each. Participants trained, under supervision of an experimenter, on weekdays in the clinic. The training consisted of two tasks: the Symmetry Span and the N-back Task. Participants in the experimental group executed versions of these task that adapt to their working memory capacity, to train their working memory optimally.
The working memory training started the day after the pre-test and included 24 sessions of 25 minutes each. Participants trained, under supervision of an experimenter, on weekdays in the clinic. The training consisted of two tasks: the Symmetry Span and the N-back Task. Participants in the placebo group executed easy versions of these task that did not adapt to their level, to prevent training.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The 14-item Desires for Drug Questionnaire (DDQ) and the 13-item Desires for Alcohol Questionnaire (DAQ) measure instant craving to respectively drug and alcohol. The DDQ is based on the DAQ.
The Obsessive Compulsive Drug Use Scale (OCDUS) and Obsessive Compulsive Drinking Scale (OCDS) measure the subjective interference and distress caused by respectively drug and alcohol related thoughts and compulsive-behavior patterns.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The Digit Span task consists of two parts: the forward Digit Span is a frequently used measure for short term memory, an important subcomponent of the memory system (Shipstead, Redick, & Engle, 2012) and the backward version measures WM.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The Reading Span measures the processing and storage functions of WM (Shipstead et al., 2012), specifically participants' ability to shift between two tasks and to cope with proactive interference.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The 30-item Barratt Impulsivity Scale-11 (BIS-11) measures impulsivity.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The Stroop measures participants' attention bias for addiction related stimuli.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The Beck Depression Inventory - Second Edition (BDI-II) measures the severity of depression in 21 statements, with four levels of increasing severity each.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The State-Trait Anxiety Inventory (STAI) measures self-reported anxiety in 40 questions on a 4-point scale. The questionnaire consists of two parts; state and trait anxiety, respectively transient and dispositional anxiety.
Time frame: Pre (baseline), post (after 4 weeks of training-starting 1 day after pre-test) and follow-up (2 months after post-test)
The Addiction Severity Index (ASI) is a semi-structured interview that measures the severity of addiction in 25 questions concerning seven problem areas: medical problems, employment problems, drug use, alcohol use, family and social problems, criminality, and psychiatric problems. We used three of these questions to assess the severity of participants' abuse problems.
Erasmus Medical Center
Other
A Randomized Double-blind Placebo-controlled Trial to Working Memory Training in Substance Abusers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06346353
Addiction, Alcohol
Mannheim, Germany
View Trial DetailsNCT04342494
Addiction, Anxiety
Ann Arbor, Michigan, United States
View Trial DetailsNCT07737652
Anxiety, Anxiety Disorders
Tuscaloosa, Alabama, United States
View Trial DetailsNCT07621731
Aberrant Motor Behavior in Dementia, Aggression
Ngoma, Eastern Province, Rwanda
View Trial Details